Get the Stockscreener App
1.41
1.44%
0.02
After Hours:
1.43
0.02
+1.42%
Cibus Inc stock is traded at $1.41, with a volume of 205.72K.
It is up +1.44% in the last 24 hours and up +9.30% over the past month.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
See More
Previous Close:
$1.39
Open:
$1.39
24h Volume:
205.72K
Relative Volume:
0.48
Market Cap:
$107.63M
Revenue:
$4.29M
Net Income/Loss:
$-104.03M
P/E Ratio:
-0.7163
EPS:
-1.9685
Net Cash Flow:
$-50.65M
1W Performance:
-1.40%
1M Performance:
+9.30%
6M Performance:
-39.74%
1Y Performance:
-9.03%
1-Day Range:
$1.36
$1.48
1-Week Range:
$1.3501
$1.51
52-Week Range:
$1.09
$4.1907
Cibus Inc Stock (CBUS) Company Profile
Name
Cibus Inc
Sector
Industry
Phone
(858) 450-0008
Address
6455 NANCY RIDGE DRIVE, SAN DIEGO
Compare CBUS vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CBUS
Cibus Inc
|
1.41 | 104.57M | 4.29M | -104.03M | -50.65M | -1.9685 |
VRTX
Vertex Pharmaceuticals Inc
|
529.59 | 126.07B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
649.81 | 65.37B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
916.80 | 57.70B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
313.04 | 40.19B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
189.99 | 39.82B | 742.00K | -1.37B | -1.07B | -7.0731 |
Cibus Inc Stock (CBUS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-29-24 | Initiated | Alliance Global Partners | Buy |
| Jul-19-24 | Resumed | Canaccord Genuity | Buy |
| Oct-09-23 | Initiated | H.C. Wainwright | Buy |
| Jul-19-23 | Resumed | Canaccord Genuity | Buy |
Cibus Inc Stock (CBUS) Latest News
Enterprise value to EBIT forward of Cibus, Inc. – NASDAQ:CBUS - TradingView
Enterprise value to EBITDA forward of Cibus, Inc. – NASDAQ:CBUS - TradingView
CBUS Forecast — Price Target — Prediction for 2027 - TradingView
Enterprise value to revenue forward of Cibus, Inc. – NASDAQ:CBUS - TradingView
Cibus, Inc. Class A Actuals & Estimates (NASDAQ:CBUS) - TradingView
Price to earnings forward of Cibus, Inc. – NASDAQ:CBUS - TradingView
Price to sales forward of Cibus, Inc. – NASDAQ:CBUS - TradingView
CBUS Q1 2026 Earnings: Narrow EPS Beat Amid Zero RevenueCFO Commentary Report - dars.gov.et
Cibus Inc (CBUS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Cibus Inc (CBUS) Institutional Confidence - TradingKey
Cibus Inc (CBUS) Valuation: PE, PB & Fair Value Analysis - TradingKey
Cibus Inc (CBUS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Cibus Inc (CBUS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Cibus Inc (CBUS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Cibus Inc (CBUS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Cibus Inc (CBUS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Cibus Inc (CBUS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Europe Recognizes Nature-Based Plant Improvement, Opening a New Pathway for Cibus - The Manila Times
Cibus Inc. (CBUS) Slides 1.6% as Stock Tests Key Support Near $1.17Merger Arbitrage - newsline.com
Cibus names board member Craig Wichner as new CEO - MSN
Cibus (CBUS) CEO receives 894K RSUs and 1.05M stock options grant - Stock Titan
Cibus Resets Leadership and Board to Drive Commercialization - The Globe and Mail
Cibus, Inc. Appoints Craig Wichner as CEO to Lead Next Phase of Growth and Innovation in Agricultural Biotechnology - Minichart
Cibus (NASDAQ: CBUS) taps Farmland LP founder Craig Wichner as CEO - Stock Titan
Cibus Names Board Member Craig Wichner as CEO - Moomoo
Cibus appoints Craig Wichner as chief executive officer By Investing.com - Investing.com Australia
Cibus (CBUS) Announces Leadership Changes - GuruFocus
Cibus Appoints New CEO to Drive Commercialization - Intellectia AI
Cibus appoints Craig Wichner as chief executive officer - Investing.com
Cibus, Inc. Announces Leadership Transition with Appointment of Craig Wichner as CEO - Quiver Quantitative
Farmland investor Craig Wichner becomes Cibus CEO, targets commercialization - Stock Titan
Cibus Q1 earnings call highlights - MSN
Cibus Stockholders Approve Directors and Governance Measures - The Globe and Mail
Cibus, Inc. 2026 Annual Meeting Results: Director Elections, Executive Compensation Approval, and Auditor Ratification (Form 8-K) – Minichart - Minichart
Cibus (CBUS) 2026 meeting backs board slate, executive pay and BDO - Stock Titan
Cibus (CBUS) director receives grant of 77,586 stock options - Stock Titan
Cibus (CBUS) director Moretti granted 77,586 options at $1.39 strike - Stock Titan
Stock option grant for Cibus (CBUS) director Rory B. Riggs - Stock Titan
Cibus (CBUS) director Gerhard Prante awarded 64,748 RSUs in equity grant - Stock Titan
Cibus (NASDAQ: CBUS) director awarded 64,748 RSUs in new stock grant - Stock Titan
Cibus (CBUS) director Kimberly Ann Box receives 77,586 stock options at $1.39 strike - Stock Titan
Cibus (CBUS) director Craig Wichner granted 77,586 stock options at $1.39 strike - Stock Titan
Director Urban Thomas awarded 64,748 Cibus (CBUS) shares in Form 4 filing - Stock Titan
Cibus (CBUS) upgraded to buy: What does it mean for the stock? - MSN
Cibus Inc. Q1 2026 Earnings: Smaller-Than-Expected Loss, Stock Edges LowerProduct Revenue Analysis - Město Břeclav
Cibus outlines runway into late Q1 2027 while shifting US rice launch to 2029 - MSN
Cibus Global LLC (NASDAQ: CBUS) Share Price, CBUS Stock News, CBUS Share Price & Updates - Kalkine
CBUSCibus Inc Stock Price and Quote - Finviz
Cibus Inc. Q1 2026 Earnings: Narrowed Loss Surprises Estimates Amid Pre-Revenue ProgressEarnings Trend Analysis - The Legal Advocate
[EFFECT] Cibus, Inc. SEC Filing - Stock Titan
Cibus Inc. Q1 2026 Earnings: Narrowing Losses Amid Pre-Revenue PhaseAdjusted Earnings Analysis - The Legal Advocate
Cibus Inc Stock (CBUS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
0.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):